相关实验视频
Updated: Jul 15, 2025

09:15
In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
676
免疫性血小板缺血患者的血栓性并发症 患者接受了阿瓦特罗姆波巴格治疗
Mahmoud Abdelsamia1, Saira Farid2, Steven Dean2
1Department of Medicine, Michigan State University, East Lansing, MI 48824, USA.
Hematology reports
|September 27, 2023
概括
治疗慢性免疫性血栓缩 (cITP) 的Avatrombopag可能与血栓事件有关. 这些罕见的并发症,包括肺栓塞和动脉/静脉血栓症,需要在接受这种血栓蛋白酶受体激动剂的患者中进一步调查.
科学领域:
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 阿瓦特罗姆波帕格是一种口服的非类血栓蛋白受体激动剂 (TPO-RA),已被批准用于慢性免疫血栓缩 (cITP).
- 之前的报道显示了良好的疗效和耐受性,对血栓性并发症的数据有限.
研究的目的:
- 报告治疗cITP的阿瓦特朗波巴格患者的潜在血栓并发症.
- 为了突出血栓栓塞事件的发生,尽管药物的一般安全性.
主要方法:
- 两名患有cITP的患者接受avatrombopag的病例报告呈现.
- 详细的临床病史,治疗过程和不良事件监测.
主要成果:
- 患者1:在开始治疗耐火性cITP的阿瓦特罗姆博帕格治疗三周后发生肺栓塞.
- 患者2:在开始服用阿瓦特朗博巴四周后,经历了动脉和静脉血栓事件,在再次挑战时复发.
结论:
- 血栓塞栓事件,包括肺栓塞和动脉和静脉血栓症,可能发生在患者治疗avatrombopag.
- 这些发现表明,阿瓦特罗姆波巴和血栓并发症之间存在潜在的关联,需要进一步调查.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Anticoagulant Drugs: Low-Molecular-Weight Heparins
741
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
741
Venous Thrombosis I: Introduction
12
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
12
Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Disorders of Hemostasis
982
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
982

